We've found
3,628
archived clinical trials in
Schizophrenia
We've found
3,628
archived clinical trials in
Schizophrenia
Randomized, Double-blind, Placebo Controlled, Multi-center and Tolerability of RBP-7000 in Schizophrenia Patients
Updated: 12/31/1969
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety and Tolerability of RBP-7000 as a Treatment in Subjects With Acute Schizophrenia Over 8 Weeks (2 Subcutaneous Doses)
Status: Enrolling
Updated: 12/31/1969
Randomized, Double-blind, Placebo Controlled, Multi-center and Tolerability of RBP-7000 in Schizophrenia Patients
Updated: 12/31/1969
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety and Tolerability of RBP-7000 as a Treatment in Subjects With Acute Schizophrenia Over 8 Weeks (2 Subcutaneous Doses)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Randomized, Double-blind, Placebo Controlled, Multi-center and Tolerability of RBP-7000 in Schizophrenia Patients
Updated: 12/31/1969
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety and Tolerability of RBP-7000 as a Treatment in Subjects With Acute Schizophrenia Over 8 Weeks (2 Subcutaneous Doses)
Status: Enrolling
Updated: 12/31/1969
Randomized, Double-blind, Placebo Controlled, Multi-center and Tolerability of RBP-7000 in Schizophrenia Patients
Updated: 12/31/1969
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety and Tolerability of RBP-7000 as a Treatment in Subjects With Acute Schizophrenia Over 8 Weeks (2 Subcutaneous Doses)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Randomized, Double-blind, Placebo Controlled, Multi-center and Tolerability of RBP-7000 in Schizophrenia Patients
Updated: 12/31/1969
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety and Tolerability of RBP-7000 as a Treatment in Subjects With Acute Schizophrenia Over 8 Weeks (2 Subcutaneous Doses)
Status: Enrolling
Updated: 12/31/1969
Randomized, Double-blind, Placebo Controlled, Multi-center and Tolerability of RBP-7000 in Schizophrenia Patients
Updated: 12/31/1969
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety and Tolerability of RBP-7000 as a Treatment in Subjects With Acute Schizophrenia Over 8 Weeks (2 Subcutaneous Doses)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Randomized, Double-blind, Placebo Controlled, Multi-center and Tolerability of RBP-7000 in Schizophrenia Patients
Updated: 12/31/1969
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety and Tolerability of RBP-7000 as a Treatment in Subjects With Acute Schizophrenia Over 8 Weeks (2 Subcutaneous Doses)
Status: Enrolling
Updated: 12/31/1969
Randomized, Double-blind, Placebo Controlled, Multi-center and Tolerability of RBP-7000 in Schizophrenia Patients
Updated: 12/31/1969
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety and Tolerability of RBP-7000 as a Treatment in Subjects With Acute Schizophrenia Over 8 Weeks (2 Subcutaneous Doses)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Randomized, Double-blind, Placebo Controlled, Multi-center and Tolerability of RBP-7000 in Schizophrenia Patients
Updated: 12/31/1969
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety and Tolerability of RBP-7000 as a Treatment in Subjects With Acute Schizophrenia Over 8 Weeks (2 Subcutaneous Doses)
Status: Enrolling
Updated: 12/31/1969
Randomized, Double-blind, Placebo Controlled, Multi-center and Tolerability of RBP-7000 in Schizophrenia Patients
Updated: 12/31/1969
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety and Tolerability of RBP-7000 as a Treatment in Subjects With Acute Schizophrenia Over 8 Weeks (2 Subcutaneous Doses)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Randomized, Double-blind, Placebo Controlled, Multi-center and Tolerability of RBP-7000 in Schizophrenia Patients
Updated: 12/31/1969
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety and Tolerability of RBP-7000 as a Treatment in Subjects With Acute Schizophrenia Over 8 Weeks (2 Subcutaneous Doses)
Status: Enrolling
Updated: 12/31/1969
Randomized, Double-blind, Placebo Controlled, Multi-center and Tolerability of RBP-7000 in Schizophrenia Patients
Updated: 12/31/1969
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety and Tolerability of RBP-7000 as a Treatment in Subjects With Acute Schizophrenia Over 8 Weeks (2 Subcutaneous Doses)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Randomized, Double-blind, Placebo Controlled, Multi-center and Tolerability of RBP-7000 in Schizophrenia Patients
Updated: 12/31/1969
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety and Tolerability of RBP-7000 as a Treatment in Subjects With Acute Schizophrenia Over 8 Weeks (2 Subcutaneous Doses)
Status: Enrolling
Updated: 12/31/1969
Randomized, Double-blind, Placebo Controlled, Multi-center and Tolerability of RBP-7000 in Schizophrenia Patients
Updated: 12/31/1969
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety and Tolerability of RBP-7000 as a Treatment in Subjects With Acute Schizophrenia Over 8 Weeks (2 Subcutaneous Doses)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Randomized, Double-blind, Placebo Controlled, Multi-center and Tolerability of RBP-7000 in Schizophrenia Patients
Updated: 12/31/1969
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety and Tolerability of RBP-7000 as a Treatment in Subjects With Acute Schizophrenia Over 8 Weeks (2 Subcutaneous Doses)
Status: Enrolling
Updated: 12/31/1969
Randomized, Double-blind, Placebo Controlled, Multi-center and Tolerability of RBP-7000 in Schizophrenia Patients
Updated: 12/31/1969
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety and Tolerability of RBP-7000 as a Treatment in Subjects With Acute Schizophrenia Over 8 Weeks (2 Subcutaneous Doses)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Minocycline Augmentation to Clozapine
Updated: 12/31/1969
A Pilot Study of Minocycline Augmentation to Clozapine in Individuals With Treatment Resistant Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Minocycline Augmentation to Clozapine
Updated: 12/31/1969
A Pilot Study of Minocycline Augmentation to Clozapine in Individuals With Treatment Resistant Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
rTMS in First Episode Psychosis
Updated: 12/31/1969
Cortical Activation and Cognitive Performance During Repetitive Transcranial Magnetic Stimulation in First-Episode Psychosis: A Pilot Study
Status: Enrolling
Updated: 12/31/1969
rTMS in First Episode Psychosis
Updated: 12/31/1969
Cortical Activation and Cognitive Performance During Repetitive Transcranial Magnetic Stimulation in First-Episode Psychosis: A Pilot Study
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
rTMS in First Episode Psychosis
Updated: 12/31/1969
Cortical Activation and Cognitive Performance During Repetitive Transcranial Magnetic Stimulation in First-Episode Psychosis: A Pilot Study
Status: Enrolling
Updated: 12/31/1969
rTMS in First Episode Psychosis
Updated: 12/31/1969
Cortical Activation and Cognitive Performance During Repetitive Transcranial Magnetic Stimulation in First-Episode Psychosis: A Pilot Study
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Self-Management Training and Automated Telehealth to Improve SMI Health Outcomes
Updated: 12/31/1969
Self-Management Training and Automated Telehealth to Improve SMI Health Outcomes
Status: Enrolling
Updated: 12/31/1969
Self-Management Training and Automated Telehealth to Improve SMI Health Outcomes
Updated: 12/31/1969
Self-Management Training and Automated Telehealth to Improve SMI Health Outcomes
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Self-Management Training and Automated Telehealth to Improve SMI Health Outcomes
Updated: 12/31/1969
Self-Management Training and Automated Telehealth to Improve SMI Health Outcomes
Status: Enrolling
Updated: 12/31/1969
Self-Management Training and Automated Telehealth to Improve SMI Health Outcomes
Updated: 12/31/1969
Self-Management Training and Automated Telehealth to Improve SMI Health Outcomes
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Long Term Study of RBP 7000 in the Treatment of Subjects With Schizophrenia
Updated: 12/31/1969
An Open-Label, Long-Term Safety and Tolerability Study of RBP-7000 in the Treatment of Subjects With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Long Term Study of RBP 7000 in the Treatment of Subjects With Schizophrenia
Updated: 12/31/1969
An Open-Label, Long-Term Safety and Tolerability Study of RBP-7000 in the Treatment of Subjects With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Long Term Study of RBP 7000 in the Treatment of Subjects With Schizophrenia
Updated: 12/31/1969
An Open-Label, Long-Term Safety and Tolerability Study of RBP-7000 in the Treatment of Subjects With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Long Term Study of RBP 7000 in the Treatment of Subjects With Schizophrenia
Updated: 12/31/1969
An Open-Label, Long-Term Safety and Tolerability Study of RBP-7000 in the Treatment of Subjects With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Long Term Study of RBP 7000 in the Treatment of Subjects With Schizophrenia
Updated: 12/31/1969
An Open-Label, Long-Term Safety and Tolerability Study of RBP-7000 in the Treatment of Subjects With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Long Term Study of RBP 7000 in the Treatment of Subjects With Schizophrenia
Updated: 12/31/1969
An Open-Label, Long-Term Safety and Tolerability Study of RBP-7000 in the Treatment of Subjects With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Long Term Study of RBP 7000 in the Treatment of Subjects With Schizophrenia
Updated: 12/31/1969
An Open-Label, Long-Term Safety and Tolerability Study of RBP-7000 in the Treatment of Subjects With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Long Term Study of RBP 7000 in the Treatment of Subjects With Schizophrenia
Updated: 12/31/1969
An Open-Label, Long-Term Safety and Tolerability Study of RBP-7000 in the Treatment of Subjects With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Long Term Study of RBP 7000 in the Treatment of Subjects With Schizophrenia
Updated: 12/31/1969
An Open-Label, Long-Term Safety and Tolerability Study of RBP-7000 in the Treatment of Subjects With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Long Term Study of RBP 7000 in the Treatment of Subjects With Schizophrenia
Updated: 12/31/1969
An Open-Label, Long-Term Safety and Tolerability Study of RBP-7000 in the Treatment of Subjects With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Long Term Study of RBP 7000 in the Treatment of Subjects With Schizophrenia
Updated: 12/31/1969
An Open-Label, Long-Term Safety and Tolerability Study of RBP-7000 in the Treatment of Subjects With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Long Term Study of RBP 7000 in the Treatment of Subjects With Schizophrenia
Updated: 12/31/1969
An Open-Label, Long-Term Safety and Tolerability Study of RBP-7000 in the Treatment of Subjects With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Long Term Study of RBP 7000 in the Treatment of Subjects With Schizophrenia
Updated: 12/31/1969
An Open-Label, Long-Term Safety and Tolerability Study of RBP-7000 in the Treatment of Subjects With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Long Term Study of RBP 7000 in the Treatment of Subjects With Schizophrenia
Updated: 12/31/1969
An Open-Label, Long-Term Safety and Tolerability Study of RBP-7000 in the Treatment of Subjects With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Long Term Study of RBP 7000 in the Treatment of Subjects With Schizophrenia
Updated: 12/31/1969
An Open-Label, Long-Term Safety and Tolerability Study of RBP-7000 in the Treatment of Subjects With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Long Term Study of RBP 7000 in the Treatment of Subjects With Schizophrenia
Updated: 12/31/1969
An Open-Label, Long-Term Safety and Tolerability Study of RBP-7000 in the Treatment of Subjects With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Long Term Study of RBP 7000 in the Treatment of Subjects With Schizophrenia
Updated: 12/31/1969
An Open-Label, Long-Term Safety and Tolerability Study of RBP-7000 in the Treatment of Subjects With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Long Term Study of RBP 7000 in the Treatment of Subjects With Schizophrenia
Updated: 12/31/1969
An Open-Label, Long-Term Safety and Tolerability Study of RBP-7000 in the Treatment of Subjects With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Long Term Study of RBP 7000 in the Treatment of Subjects With Schizophrenia
Updated: 12/31/1969
An Open-Label, Long-Term Safety and Tolerability Study of RBP-7000 in the Treatment of Subjects With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Long Term Study of RBP 7000 in the Treatment of Subjects With Schizophrenia
Updated: 12/31/1969
An Open-Label, Long-Term Safety and Tolerability Study of RBP-7000 in the Treatment of Subjects With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Long Term Study of RBP 7000 in the Treatment of Subjects With Schizophrenia
Updated: 12/31/1969
An Open-Label, Long-Term Safety and Tolerability Study of RBP-7000 in the Treatment of Subjects With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Long Term Study of RBP 7000 in the Treatment of Subjects With Schizophrenia
Updated: 12/31/1969
An Open-Label, Long-Term Safety and Tolerability Study of RBP-7000 in the Treatment of Subjects With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Long Term Study of RBP 7000 in the Treatment of Subjects With Schizophrenia
Updated: 12/31/1969
An Open-Label, Long-Term Safety and Tolerability Study of RBP-7000 in the Treatment of Subjects With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Long Term Study of RBP 7000 in the Treatment of Subjects With Schizophrenia
Updated: 12/31/1969
An Open-Label, Long-Term Safety and Tolerability Study of RBP-7000 in the Treatment of Subjects With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Long Term Study of RBP 7000 in the Treatment of Subjects With Schizophrenia
Updated: 12/31/1969
An Open-Label, Long-Term Safety and Tolerability Study of RBP-7000 in the Treatment of Subjects With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Long Term Study of RBP 7000 in the Treatment of Subjects With Schizophrenia
Updated: 12/31/1969
An Open-Label, Long-Term Safety and Tolerability Study of RBP-7000 in the Treatment of Subjects With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Long Term Study of RBP 7000 in the Treatment of Subjects With Schizophrenia
Updated: 12/31/1969
An Open-Label, Long-Term Safety and Tolerability Study of RBP-7000 in the Treatment of Subjects With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Long Term Study of RBP 7000 in the Treatment of Subjects With Schizophrenia
Updated: 12/31/1969
An Open-Label, Long-Term Safety and Tolerability Study of RBP-7000 in the Treatment of Subjects With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Long Term Study of RBP 7000 in the Treatment of Subjects With Schizophrenia
Updated: 12/31/1969
An Open-Label, Long-Term Safety and Tolerability Study of RBP-7000 in the Treatment of Subjects With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Long Term Study of RBP 7000 in the Treatment of Subjects With Schizophrenia
Updated: 12/31/1969
An Open-Label, Long-Term Safety and Tolerability Study of RBP-7000 in the Treatment of Subjects With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Long Term Study of RBP 7000 in the Treatment of Subjects With Schizophrenia
Updated: 12/31/1969
An Open-Label, Long-Term Safety and Tolerability Study of RBP-7000 in the Treatment of Subjects With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Long Term Study of RBP 7000 in the Treatment of Subjects With Schizophrenia
Updated: 12/31/1969
An Open-Label, Long-Term Safety and Tolerability Study of RBP-7000 in the Treatment of Subjects With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Long Term Study of RBP 7000 in the Treatment of Subjects With Schizophrenia
Updated: 12/31/1969
An Open-Label, Long-Term Safety and Tolerability Study of RBP-7000 in the Treatment of Subjects With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Long Term Study of RBP 7000 in the Treatment of Subjects With Schizophrenia
Updated: 12/31/1969
An Open-Label, Long-Term Safety and Tolerability Study of RBP-7000 in the Treatment of Subjects With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Long Term Study of RBP 7000 in the Treatment of Subjects With Schizophrenia
Updated: 12/31/1969
An Open-Label, Long-Term Safety and Tolerability Study of RBP-7000 in the Treatment of Subjects With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Long Term Study of RBP 7000 in the Treatment of Subjects With Schizophrenia
Updated: 12/31/1969
An Open-Label, Long-Term Safety and Tolerability Study of RBP-7000 in the Treatment of Subjects With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Long Term Study of RBP 7000 in the Treatment of Subjects With Schizophrenia
Updated: 12/31/1969
An Open-Label, Long-Term Safety and Tolerability Study of RBP-7000 in the Treatment of Subjects With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Long Term Study of RBP 7000 in the Treatment of Subjects With Schizophrenia
Updated: 12/31/1969
An Open-Label, Long-Term Safety and Tolerability Study of RBP-7000 in the Treatment of Subjects With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Long Term Study of RBP 7000 in the Treatment of Subjects With Schizophrenia
Updated: 12/31/1969
An Open-Label, Long-Term Safety and Tolerability Study of RBP-7000 in the Treatment of Subjects With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Long Term Study of RBP 7000 in the Treatment of Subjects With Schizophrenia
Updated: 12/31/1969
An Open-Label, Long-Term Safety and Tolerability Study of RBP-7000 in the Treatment of Subjects With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Long Term Study of RBP 7000 in the Treatment of Subjects With Schizophrenia
Updated: 12/31/1969
An Open-Label, Long-Term Safety and Tolerability Study of RBP-7000 in the Treatment of Subjects With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Long Term Study of RBP 7000 in the Treatment of Subjects With Schizophrenia
Updated: 12/31/1969
An Open-Label, Long-Term Safety and Tolerability Study of RBP-7000 in the Treatment of Subjects With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Long Term Study of RBP 7000 in the Treatment of Subjects With Schizophrenia
Updated: 12/31/1969
An Open-Label, Long-Term Safety and Tolerability Study of RBP-7000 in the Treatment of Subjects With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Long Term Study of RBP 7000 in the Treatment of Subjects With Schizophrenia
Updated: 12/31/1969
An Open-Label, Long-Term Safety and Tolerability Study of RBP-7000 in the Treatment of Subjects With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Long Term Study of RBP 7000 in the Treatment of Subjects With Schizophrenia
Updated: 12/31/1969
An Open-Label, Long-Term Safety and Tolerability Study of RBP-7000 in the Treatment of Subjects With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Long Term Study of RBP 7000 in the Treatment of Subjects With Schizophrenia
Updated: 12/31/1969
An Open-Label, Long-Term Safety and Tolerability Study of RBP-7000 in the Treatment of Subjects With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Long Term Study of RBP 7000 in the Treatment of Subjects With Schizophrenia
Updated: 12/31/1969
An Open-Label, Long-Term Safety and Tolerability Study of RBP-7000 in the Treatment of Subjects With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Long Term Study of RBP 7000 in the Treatment of Subjects With Schizophrenia
Updated: 12/31/1969
An Open-Label, Long-Term Safety and Tolerability Study of RBP-7000 in the Treatment of Subjects With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Long Term Study of RBP 7000 in the Treatment of Subjects With Schizophrenia
Updated: 12/31/1969
An Open-Label, Long-Term Safety and Tolerability Study of RBP-7000 in the Treatment of Subjects With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Long Term Study of RBP 7000 in the Treatment of Subjects With Schizophrenia
Updated: 12/31/1969
An Open-Label, Long-Term Safety and Tolerability Study of RBP-7000 in the Treatment of Subjects With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Long Term Study of RBP 7000 in the Treatment of Subjects With Schizophrenia
Updated: 12/31/1969
An Open-Label, Long-Term Safety and Tolerability Study of RBP-7000 in the Treatment of Subjects With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Long Term Study of RBP 7000 in the Treatment of Subjects With Schizophrenia
Updated: 12/31/1969
An Open-Label, Long-Term Safety and Tolerability Study of RBP-7000 in the Treatment of Subjects With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Long Term Study of RBP 7000 in the Treatment of Subjects With Schizophrenia
Updated: 12/31/1969
An Open-Label, Long-Term Safety and Tolerability Study of RBP-7000 in the Treatment of Subjects With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Long Term Study of RBP 7000 in the Treatment of Subjects With Schizophrenia
Updated: 12/31/1969
An Open-Label, Long-Term Safety and Tolerability Study of RBP-7000 in the Treatment of Subjects With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Long Term Study of RBP 7000 in the Treatment of Subjects With Schizophrenia
Updated: 12/31/1969
An Open-Label, Long-Term Safety and Tolerability Study of RBP-7000 in the Treatment of Subjects With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Long Term Study of RBP 7000 in the Treatment of Subjects With Schizophrenia
Updated: 12/31/1969
An Open-Label, Long-Term Safety and Tolerability Study of RBP-7000 in the Treatment of Subjects With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Long Term Study of RBP 7000 in the Treatment of Subjects With Schizophrenia
Updated: 12/31/1969
An Open-Label, Long-Term Safety and Tolerability Study of RBP-7000 in the Treatment of Subjects With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Long Term Study of RBP 7000 in the Treatment of Subjects With Schizophrenia
Updated: 12/31/1969
An Open-Label, Long-Term Safety and Tolerability Study of RBP-7000 in the Treatment of Subjects With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Long Term Study of RBP 7000 in the Treatment of Subjects With Schizophrenia
Updated: 12/31/1969
An Open-Label, Long-Term Safety and Tolerability Study of RBP-7000 in the Treatment of Subjects With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Long Term Study of RBP 7000 in the Treatment of Subjects With Schizophrenia
Updated: 12/31/1969
An Open-Label, Long-Term Safety and Tolerability Study of RBP-7000 in the Treatment of Subjects With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Long Term Study of RBP 7000 in the Treatment of Subjects With Schizophrenia
Updated: 12/31/1969
An Open-Label, Long-Term Safety and Tolerability Study of RBP-7000 in the Treatment of Subjects With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Long Term Study of RBP 7000 in the Treatment of Subjects With Schizophrenia
Updated: 12/31/1969
An Open-Label, Long-Term Safety and Tolerability Study of RBP-7000 in the Treatment of Subjects With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Long Term Study of RBP 7000 in the Treatment of Subjects With Schizophrenia
Updated: 12/31/1969
An Open-Label, Long-Term Safety and Tolerability Study of RBP-7000 in the Treatment of Subjects With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Long Term Study of RBP 7000 in the Treatment of Subjects With Schizophrenia
Updated: 12/31/1969
An Open-Label, Long-Term Safety and Tolerability Study of RBP-7000 in the Treatment of Subjects With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Long Term Study of RBP 7000 in the Treatment of Subjects With Schizophrenia
Updated: 12/31/1969
An Open-Label, Long-Term Safety and Tolerability Study of RBP-7000 in the Treatment of Subjects With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Long Term Study of RBP 7000 in the Treatment of Subjects With Schizophrenia
Updated: 12/31/1969
An Open-Label, Long-Term Safety and Tolerability Study of RBP-7000 in the Treatment of Subjects With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Long Term Study of RBP 7000 in the Treatment of Subjects With Schizophrenia
Updated: 12/31/1969
An Open-Label, Long-Term Safety and Tolerability Study of RBP-7000 in the Treatment of Subjects With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Long Term Study of RBP 7000 in the Treatment of Subjects With Schizophrenia
Updated: 12/31/1969
An Open-Label, Long-Term Safety and Tolerability Study of RBP-7000 in the Treatment of Subjects With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Long Term Study of RBP 7000 in the Treatment of Subjects With Schizophrenia
Updated: 12/31/1969
An Open-Label, Long-Term Safety and Tolerability Study of RBP-7000 in the Treatment of Subjects With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Long Term Study of RBP 7000 in the Treatment of Subjects With Schizophrenia
Updated: 12/31/1969
An Open-Label, Long-Term Safety and Tolerability Study of RBP-7000 in the Treatment of Subjects With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Long Term Study of RBP 7000 in the Treatment of Subjects With Schizophrenia
Updated: 12/31/1969
An Open-Label, Long-Term Safety and Tolerability Study of RBP-7000 in the Treatment of Subjects With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Long Term Study of RBP 7000 in the Treatment of Subjects With Schizophrenia
Updated: 12/31/1969
An Open-Label, Long-Term Safety and Tolerability Study of RBP-7000 in the Treatment of Subjects With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Long Term Study of RBP 7000 in the Treatment of Subjects With Schizophrenia
Updated: 12/31/1969
An Open-Label, Long-Term Safety and Tolerability Study of RBP-7000 in the Treatment of Subjects With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Long Term Study of RBP 7000 in the Treatment of Subjects With Schizophrenia
Updated: 12/31/1969
An Open-Label, Long-Term Safety and Tolerability Study of RBP-7000 in the Treatment of Subjects With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials